In recent years, the incidence of intestinal impairments, such as colon cancer and inflammatory bowel disease (IBD), has been increasing in East Asian countries. Healthy dietary habits, as well as taking dietary supplements, are seen as important to preventing these impairments. Mushrooms and the hydrophilic fraction are commonly recognized for multiple nutritious functions, while the function of the lipophilic fraction remains uncertain. In this study, we investigated the effects of the lipophilic fraction containing sphingolipids, extracted from
Pleurotus citrinopileatus (golden oyster mushroom), on mice suffering from chronic colon inflammation by treatment of dextran sulfate sodium salt (DSS) as IBD models. In the experiment, mice were fed with (1) control AIN-76 standard diet or (2) AIN-76 diet supplemented with 1% ethanol extract from fruiting bodies of golden oyster mushroom (GOMEE) or (3) AIN-76 diet supplemented with 5% GOMEE. Subsequent to experimental diets for 10 days, mice were drinking water ad libitum supplemented with DSS. We found that in mice ingesting DSS for 26 days, dietary GOMEE suppressed the body weight reduction and the spleen weight increase by administration of DSS. Dietary GOMEE decreased DSS-induced chorionic crypt injury, and the ameliorative effect by 5% GOMEE diet was stronger when compared to the 1% GOMEE diet. Moreover, we researched the impact of GOMEE on the early/middle stage of inflammation in colon mucosa, by assessing levels of inflammation-related cytokines in mice ingesting DSS for 18 days. The levels of almost inflammatory cytokines and chemokines examined in the colon were significantly increased due to DSS ingestion. Dietary 5% GOMEE was correlated with a significant decrease in the levels of 5 inflammatory cytokines and 5 chemokines. These results suggested that dietary GOMEE contributes to suppression of colon inflammation and the effect is dose-dependent.
View full abstract